前列腺癌局灶治疗围手术期并发症:德国全国住院数据(GRAND)研究
基于德国2005–2023年全国住院数据,比较10 544例前列腺癌局灶治疗(FT)的围手术期并发症。HIFU占92%,尿路感染最常见(9.6%);HIFU较非HIFU尿路感染更高但血尿和ICU入住更低;同期TURP增加输血、血尿、脓毒症和尿潴留风险;FT多数并发症优于机器人根治性前列腺切除术但劣于近距离放疗。
要点
- FT总体围手术期并发症风险低,尿路感染最常见(9.6%)。
- HIFU较非HIFU尿路感染更高,但血尿和ICU入住更低。
- 同期TURP增加输血、血尿、脓毒症和尿潴留风险。
核心结论
- 这是目前关于常见前列腺癌FT并发症风险的最大流行病学比较研究,显示围手术期并发症总体风险低。
研究设计与样本
- 基于德国联邦统计局研究数据中心2005–2023年全国住院数据(GRAND)的回顾性比较研究,共纳入10 544例接受FT的患者。
主要发现
- FT患者中HIFU占92%,FT年手术量持续下降。
- 全部FT病例中最常见并发症为尿路感染(9.6%),HIFU为10%、热疗6.2%、冷冻治疗6.8%、VTP为3.9%。
- 全部病例中血尿发生率为3.6%。
- 多变量回归中,HIFU较非HIFU手术尿路感染率更高(10% vs 5.2%,P < 0.001),但血尿(3.4% vs 5.5%,P < 0.001)和ICU入住率(0.7% vs 2.2%,P < 0.001)更低。
- 同期TURP与更高的输血(P < 0.001)、血尿(P < 0.001)、脓毒症(P = 0.001)和尿潴留(P = 0.03)率相关。
关键数值与推荐
- FT多数围手术期并发症在统计学上显著差于近距离放疗。
- FT多数围手术期并发症优于机器人辅助根治性前列腺切除术。
临床怎么用
- 临床选择FT时需权衡HIFU较高的尿路感染风险与非HIFU较高的血尿和ICU入住风险。
- 应谨慎评估同期TURP,因其与输血、血尿、脓毒症和尿潴留风险升高相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the perioperative complications of the most common focal therapy (FT) modalities for prostate cancer. PATIENTS AND METHODS: We assessed the GeRmAn Nationwide inpatient Data (GRAND) from 2005 to 2023, provided by the Research Data Center of the Federal Bureau of Statistics. We compared perioperative outcomes of high-intensity focused ultrasound (HIFU), hyperthermia, irreversible electroporation of the prostate, cryotherapy, vascular photodynamic therapy of the prostate (VTP), and transurethral ultrasound ablation, as well as HIFU vs non-HIFU treatments in general. Furthermore, we evaluated the role of concomitant transurethral resection of the prostate (TURP) on perioperative complications. Finally, the complication rate of FT was also compared to brachytherapy and robot-assisted radical prostatectomy. RESULTS: A total of 10 544 underwent FT. Most patients received HIFU (92%). The number of FT cases performed annually has been steadily decreasing. The most prevalent complication (9.6%) was urinary tract infection (HIFU: 10%, hyperthermia: 6.2%, cryotherapy: 6.8%, VTP: 3.9%). Haematuria was observed in 3.6% of all cases. In the multivariable regression, HIFU was associated with higher rates of urinary tract infections (10% vs 5.2%, P < 0.001) but lower rates of haematuria (3.4% vs 5.5%, P < 0.001) and admission to the intensive care unit (0.7% vs 2.2%, P < 0.001) compared to non-HIFU procedures. Concomitant TURP was associated with higher transfusion (P < 0.001), haematuria (P < 0.001), sepsis (P = 0.001), and urinary retention rates (P = 0.03). Most perioperative complications were statistically significantly worse in patients undergoing FT compared to brachytherapy, while most perioperative complications were better after FT vs robot-assisted radical prostatectomy. CONCLUSIONS: In the largest epidemiological comparative study on the risk of complications of the most common FT for prostate cancer, we were able to show an overall low risk of perioperative complications.
引用
- Pyrgidis N, Chaloupka M, Ebner B, et al. Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study. BJU Int. 2025. PMID: 40251973. doi:10.1111/bju.16746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。